Fermented Rice Bran Supplementation Prevents the Development of Intestinal Fibrosis Due to DSS-Induced Inflammation in Mice

Autor: Tomonori Nochi, Kouichi Watanabe, Afifah Zahra Agista, Ardiansyah, Slamet Budijanto, Takuya Koseki, Halima Sultana, Hisashi Aso, Suh Ching Yang, Hitoshi Shirakawa, Jahidul Islam, Ryouta Hirakawa, Tubagus Bahtiar Rusbana, Yusuke Ohsaki, Michio Komai
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
colitis
medicine.medical_treatment
Mice
0302 clinical medicine
Fibrosis
intestinal inflammation
TX341-641
education.field_of_study
Nutrition and Dietetics
Tight junction
digestive
oral
and skin physiology

Dextran Sulfate
food and beverages
Cytokine
030211 gastroenterology & hepatology
Female
medicine.symptom
fermented rice bran
medicine.medical_specialty
Population
Inflammation
Article
03 medical and health sciences
Internal medicine
medicine
intestinal fibrosis
Animals
Colitis
education
Bran
business.industry
Nutrition. Foods and food supply
Oryza
dextran sodium sulfate
medicine.disease
digestive system diseases
Diet
carbohydrates (lipids)
Mice
Inbred C57BL

stomatognathic diseases
Disease Models
Animal

Intestinal Diseases
030104 developmental biology
Endocrinology
Dietary Supplements
Fermentation
business
Food Science
Zdroj: Nutrients, Vol 13, Iss 1869, p 1869 (2021)
Nutrients
Volume 13
Issue 6
ISSN: 2072-6643
Popis: Fermented rice bran (FRB) is known to protect mice intestines against dextran sodium sulfate (DSS)-induced inflammation
however, the restoration of post-colitis intestinal homeostasis using FRB supplementation is currently undocumented. In this study, we observed the effects of dietary FRB supplementation on intestinal restoration and the development of fibrosis after DSS-induced colitis. DSS (1.5%) was introduced in the drinking water of mice for 5 days. Eight mice were sacrificed immediately after the DSS treatment ended. The remaining mice were divided into three groups, comprising the following diets: control, 10% rice bran (RB), and 10% FRB-supplemented. Diet treatment was continued for 2 weeks, after which half the population of mice from each group was sacrificed. The experiment was continued for another 3 weeks before the remaining mice were sacrificed. FRB supplementation could reduce the general observation of colitis and production of intestinal pro-inflammatory cytokines. FRB also increased intestinal mRNA levels of anti-inflammatory cytokine, tight junction, and anti-microbial proteins. Furthermore, FRB supplementation suppressed markers of intestinal fibrosis. This effect might have been achieved via the canonical Smad2/3 activation and the non-canonical pathway of Tgf-β activity. These results suggest that FRB may be an alternative therapeutic agent against inflammation-induced intestinal fibrosis.
Databáze: OpenAIRE